Skip to main content
. 2004 Nov;78(22):12665–12667. doi: 10.1128/JVI.78.22.12665-12667.2004

TABLE 1.

Inhibition of influenza virus infection in HTBE and human nasal epithelial cell cultures by OC

Virus Culture MOIa Mean (SD) no. of infected cells/epithelial segment
Control/treated ratio Pb
Control Drug treated
A/Memphis/14/96 (HINI) HTBE 0.07 560 (60) 26 (6) 22 <0.0001
HTBE 0.25 3,100 (600) 48 (20) 65 <0.0001
HNE 0.25 230 (80) 2.0 (1.3) 120 <0.0001
A/Duck/Alberta/119/98 (HINI) HTBE 0.08 2,800 (200) 44 (15) 64 <0.0001
HTBE 0.04 1,500 (300) 36 (13) 42 <0.0001
HNE 0.04 260 (90) 0.50 (0.53) 520 <0.0001
A/Turkey/Italy/2379/99 (H7NI) HTBE 0.25 1,500 (200) 30 (12) 50 <0.0001
A/Chicken/Germany/R28/03 (H7N7) HTBE 0.002 36 (16) 0.25 (0.46)c 140 <0.0001
0.88 (0.64)d 40 <0.0001
A/Sydney/5/97-like (H3N2) HTBE 0.3 222 (22) 4.8 (1.8) 47 <0.0001
154 (39)e 1.5 0.007
210 (35)f 1.1 0.42
A/Sydney/5/97-like (H3N2) (drug-resistant NA mutant) HTBE 0.35 360 (93) 270 (52) 1.3 0.017
a

MOI, multiplicity of infection calculated on the basis of virus infectivity determined in MDCK cells.

b

P value for comparison between drug-treated and control cultures (unpaired t test).

c

Infection in the presence of 1 μM OC.

d

Infection in the presence of 0.1 μM OC.

e

OC was added to the culture 1 h after virus inoculation.

f

OC was added to the culture 4 h after virus inoculation.